Новости за 17.12.2024

1. ‘Yellowstone’ ends, apparently, with a fiery, bonkers finale  The Washington Post
2. Is ‘Yellowstone’ Ending? What To Know About The Spinoff And Season 6  Forbes
3. ‘Yellowstone’ finale had a death and a love story  CNN
4. ‘Yellowstone’ Universe Expands With Offshoot Starring Kelly Reilly & Cole Hauser  Deadline
5. Cole Hauser Will 'Miss' the 'Unbelievable Cast' of Yellowstone , But Teases 'We'll See What's Next' (Exclusive)  PEOPLE

In a shocking move, King Charles has excluded Prince Andrew from the royal family's Christmas gathering amid serious espionage allegations. Discover the details behind this unprecedented decision.

The spacious, recently built property located in the 2100 block of Ardis Drive in San Jose was sold on Nov. 7, 2024 for $4,040,000, or $952 per square foot.

Mercury News Letters to the Editor for Dec. 17, 2024

The popular fantasy romance book series From Blood and Ash is getting the small-screen treatment. Sony Pictures Television is developing author Jennifer L. Armentrout’s novels into a TV series, our sister site Deadline reports. No writer or network is attached yet. The books follow Poppy, who was “chosen from birth to usher in a new era” […]

Syria accuses Israel of using false pretexts to justify its territorial ambitions and aerial attacks.

Rep. Jasmine Crockett, D-Texas., argued misogyny and self-hatred were factors in Black men and Hispanics shifting towards President-elect Donald Trump.

Cannabis is becoming a popular tool for athletes, offering benefits like pain management, improved sleep, and reduced anxiety, though legal challenges and sports regulations persist.

The daughter of Angola's former president was described by the UK government as a "notorious kleptocrat".

The singer described 2024 as ‘the best year of my life’.

Powerful Americans have lost the will to resist Trump.

Status: Confirmed Transaction
Date: 12/17/2024
Player: Mikhail Pashnin (D)
To: Neftekhimik Nizhnekamsk
Source: You need a free account to view Transfer URL Sign In/Up

Status: Confirmed Transaction
Date: 12/17/2024
Player: Marco Costantini (G)
From: Indy Fuel
To: Asiago
Source: You need a free account to view Transfer URL Sign In/Up

Status: Confirmed Transaction
Date: 12/17/2024
Player: Kevin He (F)
From: Niagara IceDogs
To: Winnipeg Jets
Information: Entry Level
Source: You need a free account to view Transfer URL Sign In/Up

This Viewpoint discusses new pathways for researchers to seek collaboration when conducting studies on treatments for rare diseases and conditions.

This Viewpoint discusses helping dual-eligible beneficiaries navigate Medicare and Medicaid coverage options.

This Viewpoint discusses the need to address all forms of AI-generated medical disinformation, regardless of whether it involves impersonating real or fictional professionals, medical societies, or research institutions, and the part that the Federal Trade Commission can play in achieving that goal.

This work discusses unfettering methadone from outdated regulations to empower patients to access treatment and advocate for methadone's expansion in their local communities by working with pharmacies and local health systems.

This cohort study aims to determine whether patient to nurse or patient to social worker staff ratios are associated with access to kidney transplant for adolescents and young adults.

This narrative review explores treatment with surgical aortic valve replacement vs transcatheter aortic valve implantation in older adults with severe symptomatic calcific aortic stenosis, including the type and timing of valve replacement.

This randomized cluster trial examines whether thrice-weekly symptom screening with symptom feedback and management care pathways, compared with usual care, improves overall self-reported symptoms in pediatric patients with cancer.

Over the past 5 decades, clinical outcomes have significantly improved for children with cancer through the availability of new treatment regimens. However, these advancements come with treatment-related symptomatic toxicities such as nausea, fatigue, and pain that often go undetected by care teams, leading to preventable suffering and avoidable downstream consequences such as hospitalizations.

In Reply We appreciate the interest in the Bisoprolol in COPD Study (BICS) from Drs Hsu and Lai. This was a pragmatic study to investigate the effect of bisoprolol on exacerbations in patients with COPD in the UK National Health Service, with any subgroup analysis considered exploratory and hypothesis generating. Moreover, the interpretation of any subgroup analyses in BICS is particularly limited because study recruitment was curtailed by the COVID-19 pandemic.

To the Editor We read with great interest the recent randomized clinical trial assessing the effect of bisoprolol in patients with chronic obstructive pulmonary disease (COPD) who are at high risk for exacerbation. The study found that bisoprolol did not reduce the number of self-reported COPD exacerbations requiring oral corticosteroids, antibiotics, or both. Although the study provides valuable insights, we would like to express some concerns about the findings.

This study compares differences in caregiver-reported hospice quality across categories of ownership, including for-profit private equity firm (PEF)/publicly traded company (PTC)–owned and non-PEF/PTC–owned hospices as well as not-for-profit–owned hospices.